The finding that LMP also occurs with Tam concentrations that can be achieved in breast cancer tissue in vivo [41,42] suggests that Tam-mediated lysosomal damage may be a significant feature of anticancer activity of Tam. The gene discussed is PDLIM7; the disease is breast carcinoma.